The Bengaluru-based contract research, development, and manufacturing organisation (CRDMO) saw overwhelming investor demand, with the Rs 3,395-crore IPO getting subscribed 67.42 times overall.

Anthem Biosciences Ltd ended its debut trading day with a premium of over 28%. Despite the high opening figures, the company ...

Anthem Biosciences IPO listing date is today. Ahead of the listing, Anthem Biosciences IPO GMP today and analysts signal a ...

True North and Faering-backed Anthem Biosciences surges ~28% on NSE/BSE debut, reflecting strong IPO sentiment and investor ...

Anthem Biosciences shares experienced a surge after a strong stock market debut, exceeding its IPO price by 27%. Investors ...

Its shares were listed at Rs 723 apiece on the BSE, a premium of 26.85 per cent as against the IPO issue price of Rs 570.

Anthem Biosciences, a leading contract research and manufacturing organization (CRDMO), made a strong debut on the Indian ...

Key Details and Listing Information<br />The bidding for the Anthem Biosciences Initial Public Offering (IPO) took place from ...

Shares of Anthem Biosciences Ltd listed with a premium of nearly 27% against the issue price of ₹570 on Monday ...

Anthem Biosciences Ltd listed on BSE and NSE at a premium of around 27 per cent on each. Zee Business managing editor, Anil ...

Anthem Biosciences made a strong debut on the stock exchanges on Monday, listing at nearly 27 per cent premium over its ...